Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
St. Joseph's Mercy Cancer Center- Hot Springs Radiation Oncology
mi
from
Hot Springs, AR
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
St. Joseph's Mercy Cancer Center- Hot Springs Radiation Oncology
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Enloe Medical Center- Cancer Center
mi
from
Chico, CA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Enloe Medical Center- Cancer Center
mi
from
Chico, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
John Muir Medical Center
mi
from
Concord, CA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
John Muir Medical Center
mi
from
Concord, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
John B. Amos Cancer Center
mi
from
Columbus, GA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
John B. Amos Cancer Center
mi
from
Columbus, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Signature Healthcare Brockton Hospital
mi
from
Brockton, MA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Signature Healthcare Brockton Hospital
mi
from
Brockton, MA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
VA Western New York Health System
mi
from
Buffalo, NY
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
VA Western New York Health System
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Vassar Brothers Medical Center
mi
from
Poughkeepsie, NY
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Vassar Brothers Medical Center
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
CaroMont Health Comprehensive Cancer Center
mi
from
Gastonia, NC
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
CaroMont Health Comprehensive Cancer Center
mi
from
Gastonia, NC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
21st Century Oncology- Carolina Radiation Medicine
mi
from
Greenville, NC
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
21st Century Oncology- Carolina Radiation Medicine
mi
from
Greenville, NC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Allegheny General Hospital
mi
from
Pittsburgh, PA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
PeaceHealth St. Joseph Cancer Center
mi
from
Bellingham, WA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
PeaceHealth St. Joseph Cancer Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Providence Hospital - Pacific Campus; Flynn Cancer Center
mi
from
Everett, WA
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Providence Hospital - Pacific Campus; Flynn Cancer Center
mi
from
Everett, WA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated:  6/20/2012
Columbia St. Mary's Hospital
mi
from
Milwaukee, WI
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Status: Enrolling
Updated: 6/20/2012
Columbia St. Mary's Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
Peripheral Blood Molecular Staging of Breast Cancer: A Prospective Cohort Study Designed to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Peripheral Blood of Stage IV Breast Cancer Patients
Status: Enrolling
Updated:  6/21/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
Peripheral Blood Molecular Staging of Breast Cancer: A Prospective Cohort Study Designed to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Peripheral Blood of Stage IV Breast Cancer Patients
Status: Enrolling
Updated: 6/21/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
Peripheral Blood Molecular Staging of Breast Cancer: A Prospective Cohort Study Designed to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Peripheral Blood of Stage IV Breast Cancer Patients
Status: Enrolling
Updated:  6/21/2012
Medical University of South Carolina
mi
from
Charleston, SC
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
Peripheral Blood Molecular Staging of Breast Cancer: A Prospective Cohort Study Designed to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Peripheral Blood of Stage IV Breast Cancer Patients
Status: Enrolling
Updated: 6/21/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol NSC 649890) in Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Status: Enrolling
Updated:  6/22/2012
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
mi
from
Tampa, FL
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol NSC 649890) in Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Status: Enrolling
Updated: 6/22/2012
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol NSC 649890) in Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Status: Enrolling
Updated:  6/22/2012
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol NSC 649890) in Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Status: Enrolling
Updated: 6/22/2012
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1
Status: Enrolling
Updated:  6/22/2012
John Jay High School
mi
from
Cross River, NY
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1
Status: Enrolling
Updated: 6/22/2012
John Jay High School
mi
from
Cross River, NY
Click here to add this to my saved trials
Promoting a Healthier Lifestyle Among Breast Cancer Survivors
Motivational Interviewing to Promote Physical Activity in Breast Cancer Survivors
Status: Archived
Updated:  6/25/2012
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Promoting a Healthier Lifestyle Among Breast Cancer Survivors
Motivational Interviewing to Promote Physical Activity in Breast Cancer Survivors
Status: Archived
Updated: 6/25/2012
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Phase II Study of Gemcitabine, Oxaliplatin in Combination With Panitumumab in Kras/B-raf Wild-Type Unresectable or Metastatic Biliary Track and Gallbladder Cancer
Status: Enrolling
Updated:  6/26/2012
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Phase II Study of Gemcitabine, Oxaliplatin in Combination With Panitumumab in Kras/B-raf Wild-Type Unresectable or Metastatic Biliary Track and Gallbladder Cancer
Status: Enrolling
Updated: 6/26/2012
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Phase II Study of Gemcitabine, Oxaliplatin in Combination With Panitumumab in Kras/B-raf Wild-Type Unresectable or Metastatic Biliary Track and Gallbladder Cancer
Status: Enrolling
Updated:  6/26/2012
Univ of Rochester Medical Center
mi
from
Rochester, NY
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Phase II Study of Gemcitabine, Oxaliplatin in Combination With Panitumumab in Kras/B-raf Wild-Type Unresectable or Metastatic Biliary Track and Gallbladder Cancer
Status: Enrolling
Updated: 6/26/2012
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Status: Enrolling
Updated:  6/28/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Status: Enrolling
Updated: 6/28/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer
Prospective Randomized Comparison of Clamped Versus Unclamped Partial Nephrectomy
Status: Enrolling
Updated:  6/28/2012
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer
Prospective Randomized Comparison of Clamped Versus Unclamped Partial Nephrectomy
Status: Enrolling
Updated: 6/28/2012
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas
Status: Enrolling
Updated:  6/28/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas
Status: Enrolling
Updated: 6/28/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas
Status: Enrolling
Updated:  6/28/2012
Baylor College of Medicine
mi
from
Houston, TX
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas
Status: Enrolling
Updated: 6/28/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
City of Hope
mi
from
Upper San Gabriel Valley, CA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
City of Hope
mi
from
Upper San Gabriel Valley, CA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Miller Children's Hospital
mi
from
Long Beach, CA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Oakland Children's Hospital
mi
from
Oakland, CA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Oakland Children's Hospital
mi
from
Oakland, CA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Stanford Univ Med Ctr
mi
from
Stanford, CA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
UCSF School of Medicine
mi
from
San Francisco, CA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
University of Miami Cancer Center
mi
from
Miami, FL
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
University of Miami Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Childrens Memorial
mi
from
Chicago, IL
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Childrens Memorial
mi
from
Chicago, IL
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Johns Hopkins University
mi
from
Baltimore, MD
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Dana Farber
mi
from
Boston, MA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
New York University Medical Center
mi
from
New York, NY
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
New York University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Oregon Health and Science University
mi
from
Portland, OR
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
St. Jude
mi
from
Memphis, TN
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
St. Jude
mi
from
Memphis, TN
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated:  6/29/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clofarabine With Cytarabine for MRD Positive Leukemia
Status: Enrolling
Updated: 6/29/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials